Clinical Trials@2x
  • News

    Most Read

    • Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial
    • Moderna begins dosing in Covid-19 vaccine study in Japan
    • Reify Health extends StudyTeam platform availability for clinical trials

    Most Recent

    Clinical Trials

    Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial

    22 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy
    • Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market
    • Novo Nordisk’s makes strides into Alzheimer’s with anti-diabetic drug

    Most Recent

    Clinical Trials

    Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy

    12 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • NIH reports full-dose blood thinners improve Covid-19 outcome
    • Adastra eyes CRO pitches for Phase II trial of anticancer candidate; initiates $45m Series B fundraising, exec says
    • Senhwa Biosciences initiates enrolment in Covid-19 drug trial

    Most Recent

    Clinical Trials

    NIH reports full-dose blood thinners improve Covid-19 outcome

    25 Jan 2021
  • Themes
  • Deals

    Most Read

    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink
    • IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea

    Most Recent

    Clinical Trials

    Investment firm GI Partners closes Clinical Ink acquisition

    27 Aug 2020
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Linari NanoTech
    • OpenClinica
    • Strategikon Pharma

    Most Recent

    Linari NanoTech

    19 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Novavax begins Phase III Covid-19 vaccine trial in the US and Mexico

Novavax begins Phase III Covid-19 vaccine trial in the US and Mexico

Biotech firm Novavax has initiated a pivotal Phase III study of its Covid-19 vaccine candidate,...

29th December 2020
RedHill to conduct Covid-19 trial of opaganib in Mexico and Brazil

RedHill to conduct Covid-19 trial of opaganib in Mexico and Brazil

RedHill Biopharma has submitted an application to Mexico's COFEPRIS and initiated a filing with Brazil's...

23rd July 2020
Zydus gets Mexican approval to trial PegiHep for Covid-19

Zydus gets Mexican approval to trial PegiHep for Covid-19

India-based Zydus Cadila has secured approval from the Mexican regulatory agency COFEPRIS for clinical studies...

20th July 2020
India’s Zydus gets Mexican approval to trial Desidustat for Covid-19

India’s Zydus gets Mexican approval to trial Desidustat for Covid-19

India-based pharmaceutical company Zydus has received approval from the Mexican regulatory authority, COFEPRIS, to assess...

6th July 2020
CytoDyn and Mexican NIH to assess leronlimab for Covid-19

CytoDyn and Mexican NIH to assess leronlimab for Covid-19

CytoDyn is set to collaborate with the National Institutes of Health (NIH) of Mexico to...

20th May 2020
PanAmerican Clinical Research and CAIMED partner for clinical site alliance

PanAmerican Clinical Research and CAIMED partner for clinical site alliance

PanAmerican Clinical Research has partnered with Centro de Atención e Investigación Médica (CAIMED) to provide...

15th April 2020
Zhittya gets regulatory approval in Mexico for trial of drug in PD patients

Zhittya gets regulatory approval in Mexico for trial of drug in PD patients

Zhittya Genesis Medicine has secured regulatory approval from Mexico's governing body COFEPRIS to test its...

26th February 2020
Deals this week: DelSiTech, Marken, Erasca

Deals this week: DelSiTech, Marken, Erasca

DelSiTech has signed an agreement with Innovare for the development of long-acting human immunodeficiency virus (HIV)...

21st December 2018
M&As this Week: Capio, BioStem Technologies, Virtus Health

M&As this Week: Capio, BioStem Technologies, Virtus Health

Capio AB (publ) has entered an agreement to acquire 100% interest in healthcare and dental...

2nd March 2018

Latest News

Clinical Trials

Montreal Heart Institute reports positive results from Covid-19 trial

25 Jan 2021
Technology

Telemedicine to benefit the most from remote patient monitoring tools: Poll

25 Jan 2021
Clinical Trials

NIH reports full-dose blood thinners improve Covid-19 outcome

25 Jan 2021
Clinical Trials

Senhwa Biosciences initiates enrolment in Covid-19 drug trial

25 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more